News
Pfizer and BioNTech to Supply Japan with 120 Million Doses of their BNT162 mRNA-based Vaccine Candidate
Pfizer Inc and BioNTech SE announced an agreement with the Ministry of Health, Labour and Welfare (MHLW) in Japan to supply 120 million doses...
Press Releases
Novartis Cosentyx receives EU approval for first-line systemic treatment in pediatric psoriasis
Novartis, a leader in immuno-dermatology and rheumatology, announced the EC has granted the approval for Cosentyx® (secukinumab) for the treatment of moderate-to-severe plaque psoriasis...
News
Sanofi and GSK in advanced discussions with European Union to supply up to 300 million doses of COVID-19 vaccine
Sanofi and GSK are in advanced discussions, with the European Commission (EC) for the supply of up to 300 million doses of a COVID-19...
Press Releases
Raremark launches the Xperiome patient-powered knowledge platform to deliver new therapies faster and smarter
Raremark®, the leading online patient community in rare disease, has launched its patient-powered knowledge platform Xperiome™ to help the pharmaceutical industry deliver innovative new...
News
Over 300 Clinical Studies Benefit from CluePoints COVID-19 Risk Management Support
CluePoints, the premier provider of Risk-Based Study Execution (RBx) and Data Quality Oversight Software for clinical trials, announced the success of its complimentary COVID-19...
News
Abzena appoints Matthew LeClair as SVP and Site Head of San Diego Operations
Abzena, a leading Partner Research Organization (PRO) for biopharmaceutical outsourced solutions from concept to clinic and into GMP manufacturing has announced the appointment of...
News
Biocair Expands US Presence And Capacity
With the expansion of two of Biocair’s North American facilities, the company’s offerings in the US have increased substantially.
The Philadelphia office has doubled...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from up to 5 devices at once
Must read
